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Abstract Glycotripeptides generated invivo in the endoplasmic reticulum (ER) have been used as markers to assess the rate of vesicular bulk flow 
from the ER via the Golgi apparatus to the plasma membrane inmammalian cells. The applicability of such glycotripeptides as markers for bulk 
flow along this pathway has been questioned by a report on non-vesicular release of glycotripeptides from yeast semi-intact spheroplasts. We have 
therefore investigated direct release of glycotripeptides from yeast and from mammalian microsomes and report here that such release isspecific to 
the yeast system and cannot be detected inmammalian microsomes. 
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1. Introduction 
Tripeptides with a hydrophobically modified amino-termi- 
nus, a blocked carboxyl-terminus and the sequence necessary 
for N-glycosylation, Asn-Xaa-Ser/Thr, are readily taken up by 
living cells, glycosylated in the endoplasmic reticulum (ER), 
and thereafter released into the medium [1]. During secretion 
their carbohydrate moieties are trimmed and processed in a 
Golgi-specific sequence of reactions, indicating their passage 
through the complete Golgi - the secretory pathway taken by 
newly synthesized proteins [2]. This experimental design has 
allowed us to measure the rate of vesicular bulk flow from the 
ER via the Golgi apparatus to the cell surface [1]. The resulting 
data have strongly contributed to our present view that newly 
synthesized proteins enter the constitutive transport pathway 
in an unsignalled manner, and that proteins destined for loca- 
tions other than the cell surface are specifically retained at their 
residencies or directed to their destinations by signal-receptor 
interactions [3-6]. 
In order to correctly interpret kinetic data obtained in vivo 
in Chinese hamster ovary fibroblasts with these markers, their 
complete luminal inclusion during transport is a prerequisite. 
Such vesicular inclusion has been challenged by a recent publi- 
cation which describes ATP-dependent translocation of glyco- 
tripeptides across the ER membrane in yeast semi-intact sphe- 
roplasts [7]. Previous tudies have demonstrated glycopeptide 
retention within the mammalian ER [8,9], but they have not 
determined whether or not the glycopeptides are quantitatively 
retained; more importantly, not all of the factors reported nec- 
essary for glycopeptide translocation i  yeast [7] were added in 
these studies. This has prompted us to investigate inan in vitro 
system whether or not mammalian microsomes show non-ve- 
sicular release as an alternative pathway for glycotripeptide 
secretion. Our reasoning for the use of microsomes was that, 
should there be a pump in the ER which translocates glycopep- 
*Corresponding author. Fax: (49) (6221) 564 366. 
Abbreviations." ER, endoplasmic reticulum; OTP, N-octanoylated 
tripeptide Asn-Tyr-Thr-NH2; OTP(Asp), N-octanoylated tripeptide 
Asp-Tyr-Thr-NH2; ConA, concanavalin A; TLC, thin layer chroma- 
tography; GTPTS, guanosine-5'-O-(3-thiotriphosphate); ctF, yeast ct 
factor. 
tides, this pump should be detectable not just in a semi-intact 
cell system but also in microsomes. This approach as allowed 
us to directly compare yeast and mammalian ER for glyco- 
tripeptide translocation. No evidence of non-vesicular release 
from mammalian microsomes was found, whereas uch a re- 
lease from yeast microsomal preparations was confirmed. 
2. Experimental procedures 
2.1. Peptide synthesis and iodination 
OTP was synthesized by solid-phase peptide synthesis employing 
Fmoc amino acids according to [1]. 1251 iodination was performed as 
described [1] using the chloramine T procedure. Specific activity ranged 
from 1 to 2 x l0 s cprrdnmol. The iodinated tripeptide was dissolved in 
dimethyl sulfoxide at 5 x 106 cpm//al. 
2. 2. Preparation of cell fractions 
S. cerevisiae strain SKQ2N was used for the preparation of yeast 
semi-intact spheroplasts and yeast microsomes. Spheroplasting was 
performed according to Baker et al. [10]; yeast microsomes and cytosol 
were prepared essentially as described by Waters and Blobel [11]. Mi- 
crosomes and cytosols from mammalian sources were prepared accord- 
ing to Walter and Blobel [12]. 
2.3. In vitro transport reactions 
A standard 25/11 yeast incubation mixture contained 10/.tl (100-150 
/tg) microsomes or semi-intact spheroplasts, 5/~1 (80/ag) of yeast cy- 
tosol, 2 mM ATP, 10 mM creatine phosphate, 0.3/~1 (8 mg/ml; Boehrin- 
ger) creatine phosphokinase, and 50/~M each of UDP-glucose, UDP- 
N-acetylglucosarnine a dGDP-mannose in a 20 mM HEPES buffer, 
pH 6.8, containing 150 mM potassium acetate, 5 mM magnesium ace- 
tate, 1 mM dithiothreitol, 250 mM sorbitol. Incubations with mammal- 
ian microsomes were carried out in the same buffer at pH 7.5 and with 
mammalian cytosol. Incubations with yeast membranes were carried 
out at 20"C, mammalian microsomes were incubated at 30"C. At var- 
ious time points, 25/tl aliquots were taken from upscaled samples and 
layered on top of a step gradient consisting of 50/al 2.0 M sucrose and 
100/tl 0.5 M sucrose, both in incubation buffer without sorbitol. Gra- 
dients were centrifuged for 10 min at 100,000 rpm and 4"C in a 
TLA-100 rotor (Beckman): the top half was taken as supernatant, the 
bottom half as pellet fraction. Each fraction was brought to 0.5% Triton 
X-100, 1 mM CaCI2, 1 mM MnCI2, heated for 2 min to 95"C and then 
transferred onto ice. After centrifugation for 5 min in an Eppendorf 
microfuge, samples were passed through ConA-Sepharose (Pharmacia) 
columns as described [1] for quantitation f the [~25I]glycotripeptides 
formed. 
2.4. Glycotripeptide analysis 
Glycotripeptides eluted from ConA-Sepharose columns in buffer A 
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without Triton X-100 (10 mM Tris, pH 7.4, 1 mM CaC12, 1 mM MnCl2, 
0.15 M NaC1) were applied to a SepPak C-18 cartridge (Waters), 
washed with 20 ml H20, eluted with 60% acetonitrile and dried in a 
SpcedVac oncentrator. About 1-5 gl of an aqueous olution of the 
concentrate was spotted onto a silica gel thin layer plate with grooved 
channels (Whatman). Chromatography was performed in butanol/ace- 
tic acid/water (5 : 2 : 2, v/v/v). The TLC plates were dried thoroughly and 
exposed to X-ray film (Kodak XAR5) at -70°C using an intensifying 
screen (Dupont Cronex Hi-plus). 
2.5. In vitro translation 
Translation of the mRNA encoding for prepro-c~-factor was per- 
formed according to Jackson and Hunt [13]. Translation took place for 
30 min at 30°C in a reticulocyte lysate. After addition of cycloheximide 
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Fig. 1. Distribution of [125I]glycotripeptides in mammalian microsomal 
fractions. (A) Time-course of an incubation of dog pancreas micro- 
somes with 4 x 105 clam of [125I]OTP in the presence of rat liver cytosol 
and an ATP-regenerating system. ©, supernatant; e, pellet. (B) Distri- 
bution of [~25I]glycotripeptides b tween pellet and supernatant fractions 
after 60 min incubation with 1.6 x 106 cpm of [125I]OTP for different 
mammalian microsomal preparations. Dark bars indicate pellet frac- 
tions, light bars represent supernatant fractions. Values are averaged 
for separate incubations with rat liver cytosol and bovine brain cytosol. 
For dog pancreas microsomes, five individual preparations were aver- 
aged. 
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Fig. 2. Nucleotide dependence of the release of [125I]glycotripeptides 
from yeast microsomes. (A) Microsomes prepared from S. cerevisiae 
were incubated in the presence of yeast cytosol, nucleotide sugar do- 
nors, and an ATP-regenerating system with 4 x 105 cpm of [~25I]OTP 
per sample. (B) Conditions as in A, but without he ATP-regenerating 
system. (C) Conditions as in A, but in the presence of 50/zM GTP~,S. 
Vesicular and non-vesicular material was separated and quantified as 
described in section 2. Zero minute values, which typically accounted 
for about 1500 cpm in the pellet and 300 cpm in the supernatant 
fractions, were subtracted. ©, supernatant; o, pellet. 
to 1 mM, the incubation was continued for 20 min at 26°C in the 
presence or absence of yeast microsomal membranes. A further incuba- 
tion for 10 min at 26°C followed in the presence or absence of pro- 
teinase K (150 pg/ml; Boehringer). 
3. Results 
3.1. There is no time-dependent release of  [12~I]glycotripeptides 
from mammalian microsomes 
A recent report by R6misch and Schekman on glycotripep- 
tide release from yeast semi-intact spheroplasts had implied a 
route of secretion for glycopeptides alternative to the constitu- 
tive secretory pathway, questioning their applicability as mark- 
ers of vesicular bulk flow [7]. In order to determine whether 
[125I]glycotripeptides can be released under physiological condi- 
tions from mammal ian microsomes, we incubated og pancreas 
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Fig. 3. Yeast microsomal membranes do not release glycosylated pro- 
a-factor. After translation i  a reticulocyte lysate system, prepro-a- 
factor was incubated in the presence or absence of yeast microsomal 
membranes, proteinase K, and Triton X-100 as indicated. The lower 
band in lanes 3 and 4 corresponds toprepro-a-factor (preproaF) and 
pro-a-factor (where the signal sequence has been processed, proaF), the 
top band in these lanes corresponds to threefold glycosylated pro-a- 
factor (glyco-proctF). 
microsomes with [125I]OTP in the presence of rat liver cytosol, 
an ATP-regenerating system, and a mixture of sugar nucleo- 
tides (see section 2). [~2~I]Glycotripeptides w re isolated after 
high-speed centrifugation i order to separate vesicular from 
non-vesicular material (Fig. 1A). No accumulation with time 
of [~25I]glycotripeptides in the supernatant fractions could be 
detected. To investigate whether this result holds true for other 
mammalian species and tissues as well, we incubated micro- 
somes of various origins with cytosols derived from bovine 
brain, bovine liver, and, as a control, yeast. The results are 
shown in Fig. lB. The percentage of [~:5I]glycotripeptides n the 
supernatant was as follows (mean + S.D.): dog pancreas micro- 
somes, 5.03 + 1.98%; bovine liver microsomes, 4.63 + 0.80%; 
rat liver microsomes, 1.45 + 0.14%. Control incubations with 
yeast cytosol gave essentially the same results. 
In no case was a significant amount of [125I]glycotripeptides 
released into the supernatant fraction, indicating there is no 
measurable non-vesicular release of [~25I]glycotripeptides from 
the mammalian ER membrane. 
3.2. [leSI]Glycotripeptide r lease from yeast microsomes i  
blocked by GTPT'S 
Microsomes prepared from the yeast Saccharomyces cerevis- 
iae were incubated under the same conditions described above 
for dog pancreas microsomes (with yeast cytosol replacing the 
mammalian cytosol). The conditions used correspond to those 
employed by Rrmisch and Schekman for incubations with 
yeast semi-intact spheroplasts [7]. In this way, we confirmed the 
time-dependent release of [12~I]glycotripeptides ntothe super- 
natant upon addition of an ATP-regenerating system (Fig. 2A). 
This release was diminished when the ATP-regenerating system 
was omitted (Fig. 2B), although not to the same extent as had 
been reported for semi-intact spheroplasts. In the absence of 
the ATP-regenerating system there was also less overall glyco- 
sylation. Addition of ATPyS caused no further decrease in 
either glycosylation or release (not shown). However, this ATP- 
dependent release was blocked by GTPyS (Fig. 2C), a non- 
hydrolyzable analogue of GTP which is known to block vesic- 
ular transport. This had not been previously reported. Similar 
effects, although not as pronounced, were found when semi- 
intact spheroplasts were used (not shown). 
To control whether this release of glycotripeptides is due to 
leakiness of the yeast membranes, prepro-~-factor was trans- 
lated in vitro and yeast microsomes were added post-transla- 
tionally (Fig. 3). The glycosylated pro-or-factor was protected 
from proteolysis by proteinase K in the absence but not in the 
presence of Triton X-100. Therefore, it is enclosed in the lumen 
of the microsomal membranes and we confirmed that release 
of [125I]glycotripeptides is not due to leakiness of the yeast 
microsomal membranes. 
3.3. Characterization of [125I]glycotripeptide release from yeast 
microsomes 
Based on their observations with yeast semi-intact sphero- 
plasts, R6misch and Schekman suggested the existence of a 
peptide pump in the yeast ER to explain on-vesicular [125I]gly- 
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Fig. 4. Analysis of [~:5I]glycotripeptides solated from yeast micro- 
somes. (A) [~25I]Glycotripeptides isolated from pellet (lane 1) and super- 
natant fractions (lane 2), respectively, ofan incubation with yeast mi- 
crosomes. Slower migration of the glycotripeptides in lane 2 indicates 
a larger carbohydrate chain as compared to the sample in lane 1. 
(B) The material from pellet and supernatant fractions was digested 
with jack bean a-mannosidase, endo H, or mock digested as indicated. 
Arrows show migration of OTP and OTP(Asp) (N-octanoylated tripep- 
tide Asp-Tyr-Thr-NH2 resulting from digestion with N-glycanase) as 
well as the deduced peptide-bound carbohydrate structures after diges- 
tion with endo H and jack bean a-mannosidase. 
150 K. van Leyen et al./FEBS Letters 355 (1994) 147-150 
cotripeptide xport. Therefore we decided to investigate the 
specificity of this putative pump regarding carbohydrate struc- 
ture. To this end, [~25I]glycotripeptides were isolated from pellet 
and supernatant fractions of an incubation of yeast microsomes 
with [~25I]OTP. TLC analysis of the [125I]glycotripeptides 
showed a markedly slower migration of a major portion of the 
supernatant fraction as compared to the pellet fraction (Fig. 
4A), indicating a significantly larger carbohydrate chain. The 
percentage of slower-migrating material in the supernatant 
fraction varied, but in each case it constituted the most prom- 
inent spot in TLC, while it was hardly detectable in the pelleted 
fraction. Since digestion with ct-mannosidase cl aved all of the 
[~25I]glycotripeptide sp cies (Fig. 4B, lanes 3 and 7), leaving a 
single spot presumably representing the Manfll-4GlcNAcfll- 
4GlcNAc-trisaccharide connected to OTP, the presence of glu- 
cose residues, which could also be expected for ER-derived 
carbohydrate chains [14], can be ruled out. This modification 
of the carbohydrate chain is not due to a process taking place 
on the cytosolic side of the membranes, as the faster-migrating 
material isolated from the pellet fraction does not become mod- 
ified during re-incubation with yeast microsomes and cytosol 
(not shown). 
4. Discussion 
The mechanism of non-vesicular release of glycotripeptides 
from yeast ER is unclear. In agreement with Rrmisch and 
Schekman we have found some stimulation by ATP of release 
of glycotripeptides from yeast microsomes, and in addition we 
found this release to be blocked by GTP~'S. In our hands, 
release was not dependent on the addition of cytosol, as had 
been reported [7], but this may be due to the high membrane 
concentrations u ed and concomitant contamination with cy- 
tosolic factors in our assay system. Interestingly, the [125I]gly- 
cotripeptides i olated from the supernatants of these incuba- 
tions have a larger carbohydrate moiety than those found in the 
membrane-enclosed fraction. Previous investigations on the 
carbohydrate chains of glycoproteins i olated from the yeast 
ER had shown only minor variations in chain size, correspond- 
ing to GlcNAc2Mans and GlcNAc2Man9 structures [14]. No 
mechanisms are known for the elongation of carbohydrate 
chains in the cytosol, and no modification of [~25I]glycotripep- 
tides added exogenously to control incubations was observed 
(not shown). It should be considered that yeast microsomes 
represent a less well-defined membrane fraction than their 
mammalian counterparts. Thus, it cannot be excluded that the 
[~25I]glycotripeptides isolated from the supematant had first 
been released from the ER in vesicular form and subsequently 
released to the medium. 
Most importantly, however, a non-vesicular release of gly- 
cotripeptides from the mammalian ER seems highly unlikely, 
based on the results with mammalian microsomes presented 
here. Neither microsomes from cells containing a high percent- 
age of rough ER (dog pancreas) nor those from cells enriched 
in smooth ER (rat liver) release significant amounts of [125I]gly- 
cotripeptides under conditions where such a release is found 
from yeast microsomes. This is consistent with complete Golgi 
passage of glycotripeptides observed in vivo, and establishes the 
applicability of the glycotripeptides a markers for vesicular 
bulk flow from the ER to the plasma membrane in mammalian 
cells. 
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